Four years ago, a Northwest Arkansas man whose melanoma had spread to his brain became the first person in the world to receive an experimental cancer drug at Highlands Oncology Research Center. Read More Rooted in Community Highlands Oncology celebrated the grand...
Anniversary celebrated with reception highlighting changes in cancer treatment. ROGERS — Highlands Oncology celebrated its 30th anniversary Saturday evening, highlighting changes in cancer care in Northwest Arkansas. Read...
Springdale-based cancer-care provider Highlands Oncology recently invested about $4 million in an expanded Clinical Trials Suite amid rapid growth in its clinical trials program, which has received approval to participate in first-in-human clinical trials. Read...
Identifiying individuals with hereditary cancer gene mutations has become an essential part of cancer prevention, early detection, and cancer treatment, making the integration of genetic counseling into oncology practice increasingly important in Arkansas and beyond....
A recent discussion between ACCC and Highlands Oncology centered on how artificial intelligence can be implemented thoughtfully in cancer care to support clinicians and operations without compromising clinical judgement or patient care. Read...
The importance of postmastectomy radiation in appropriately selected patients has been demonstrated in a multitude of trials since the 1970s, showing improvements in not just local control but also overall survival. Despite this, there are many toxicities associated...
